Related Experiment Video
Updated: Nov 6, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Diagnosis and management of coronavirus disease-associated immune thrombocytopenia: a case series
Fatma Yılmaz Aydın1, Vehbi Demircan2
1University of Dicle, School of Medicine, Department of Internal Medicine, Diyarbakır, Turkey.
Insights
Two patients with coronavirus disease (COVID-19) developed immune thrombocytopenia, a rare but serious complication. This case series details their clinical journey, treatment, and outcomes, highlighting a potential link between COVID-19 and this bleeding disorder.
Area of Science:
- Hematology
- Infectious Diseases
- Internal Medicine
Background:
- Coronavirus disease (COVID-19) is associated with various health issues and fatal complications.
- Immune thrombocytopenia (ITP) is known to occur with viral infections, but its link to COVID-19 is infrequently reported.
- Understanding COVID-19's impact on platelet count is crucial for patient management.
Abstract:
Data on health problems and fatal complications associated with coronavirus disease (COVID-19) have consistently been reported. Although immune thrombocytopenia has been associated with multiple viral infections, only few studies have shown its association with COVID-19. Here, we have reported a case series of two cases pertaining to patients diagnosed with COVID-19-associated immune thrombocytopenia, elaborating on the clinical course, management, and response to treatment.
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Acute Pyelonephritis II: Diagnostic Studies and Management
Nephrotic Syndrome II : Assessment and Medical Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Endocarditis III: Medical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention

